Background: Little is known about health-related quality of life (HRQOL) following treatment for bladder cancer (BC).
Objective: To determine this, we undertook a cross-sectional survey covering 10% of the English population.
Design, Setting, And Participants: Participants 1-10 yr from diagnosis were identified through national cancer registration data.